{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:06:14Z","timestamp":1791241574885,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,17]]},"DOI":"10.7759\/cureus.69613","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T20:57:23Z","timestamp":1726606643000},"source":"Crossref","is-referenced-by-count":7,"title":["Parkinson's Disease Treatment: A Bibliometric Analysis"],"prefix":"10.7759","author":[{"given":"Billy","family":"McBenedict","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelmina N","family":"Hauwanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Ienaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulci","family":"Petrus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda Sukaina","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonatha","family":"Machado Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barakat B","family":"Onabanjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asaju","family":"Felix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujood","family":"Awadelseed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivadeva","family":"Selvamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phoh","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Lima Pess\u00f4a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-7568(24)00094-1","article-title":"Temporal trends in the prevalence of Parkinson's disease from 1980 to 2023: a systematic review and meta-analysis","volume":"5","author":"Zhu J","year":"2024","unstructured":"Zhu J, Cui Y, Zhang J, et al.. Temporal trends in the prevalence of Parkinson's disease from 1980 to 2023: a systematic review and meta-analysis. Lancet Healthy Longev. 2024, 5:464-479. 10.1016\/S2666-7568(24)00094-1","journal-title":"Lancet Healthy Longev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27802","article-title":"Update of the MDS research criteria for prodromal Parkinson's disease","volume":"34","author":"Heinzel S","year":"2019","unstructured":"Heinzel S, Berg D, Gasser T, Chen H, Yao C, Postuma RB. Update of the MDS research criteria for prodromal Parkinson's disease. Mov Disord. 2019, 34:1464-1470. 10.1002\/mds.27802","journal-title":"Mov Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson's disease","volume":"122","author":"Damier P","year":"1999","unstructured":"Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain. 1999, 122:1437-1448. 10.1093\/brain\/122.8.1437","journal-title":"Brain"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem BR","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson's disease. Lancet. 2021, 397:2284-2303. 10.1016\/S0140-6736(21)00218-X","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809983","article-title":"Randomized delayed-start trial of levodopa in Parkinson's disease","volume":"380","author":"Verschuur CV","year":"2019","unstructured":"Verschuur CV, Suwijn SR, Boel JA, et al.. Randomized delayed-start trial of levodopa in Parkinson's disease. N Engl J Med. 2019, 380:315-324. 10.1056\/NEJMoa1809983","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18030551","article-title":"Parkinson's disease: from pathogenesis to pharmacogenomics","volume":"18","author":"Cacabelos R","year":"2017","unstructured":"Cacabelos R. Parkinson's disease: from pathogenesis to pharmacogenomics. Int J Mol Sci. 2017, 18:551. 10.3390\/ijms18030551","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-019-0229-z","article-title":"Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good","volume":"13","author":"Krebs K","year":"2019","unstructured":"Krebs K, Milani L. Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good. Hum Genomics. 2019, 13:39. 10.1186\/s40246-019-0229-z","journal-title":"Hum Genomics"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907083","article-title":"Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease","volume":"362","author":"Follett KA","year":"2010","unstructured":"Follett KA, Weaver FM, Stern M, et al.. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med. 2010, 362:2077-2091. 10.1056\/NEJMoa0907083","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl346","article-title":"Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease","volume":"130","author":"Stefani A","year":"2007","unstructured":"Stefani A, Lozano AM, Peppe A, et al.. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain. 2007, 130:1596-1607. 10.1093\/brain\/awl346","journal-title":"Brain"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1227\/NEU.0b013e31822b6f71","article-title":"Pedunculopontine nucleus stimulation improves gait freezing in Parkinson disease","volume":"69","author":"Thevathasan W","year":"2011","unstructured":"Thevathasan W, Coyne TJ, Hyam JA, Kerr G, Jenkinson N, Aziz TZ, Silburn PA. Pedunculopontine nucleus stimulation improves gait freezing in Parkinson disease. Neurosurgery. 2011, 69:1248-1254. 10.1227\/NEU.0b013e31822b6f71","journal-title":"Neurosurgery"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.3098","article-title":"Safety and efficacy of focused ultrasound thalamotomy for patients with medication-refractory, tremor-dominant Parkinson disease: a randomized clinical trial","volume":"74","author":"Bond AE","year":"2017","unstructured":"Bond AE, Shah BB, Huss DS, et al.. Safety and efficacy of focused ultrasound thalamotomy for patients with medication-refractory, tremor-dominant Parkinson disease: a randomized clinical trial. JAMA Neurol. 2017, 74:1412-1418. 10.1001\/jamaneurol.2017.3098","journal-title":"JAMA Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30403-9","article-title":"Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study","volume":"17","author":"Mart\u00ednez-Fern\u00e1ndez R","year":"2018","unstructured":"Mart\u00ednez-Fern\u00e1ndez R, Rodr\u00edguez-Rojas R, Del \u00c1lamo M, et al.. Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study. Lancet Neurol. 2018, 17:54-63. 10.1016\/S1474-4422(17)30403-9","journal-title":"Lancet Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11192-015-1645-z","article-title":"The bibliometric analysis of scholarly production: how great is the impact?","volume":"105","author":"Ellegaard O","year":"2015","unstructured":"Ellegaard O, Wallin JA. The bibliometric analysis of scholarly production: how great is the impact?. Scientometrics. 2015, 105:1809-1831. 10.1007\/s11192-015-1645-z","journal-title":"Scientometrics"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe W","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, et al.. Parkinson disease. Nat Rev Dis Primers. 2017, 3:17013. 10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203925","article-title":"Exploring aging interventions in human brain organoids","volume":"14","author":"Aguado J","year":"2022","unstructured":"Aguado J, Wolvetang EJ. Exploring aging interventions in human brain organoids. Aging (Albany NY). 2022, 14:1592-1593. 10.18632\/aging.203925","journal-title":"Aging (Albany NY)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong MJ","year":"2020","unstructured":"Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020, 323:548-560. 10.1001\/jama.2019.22360","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil M","year":"2018","unstructured":"Khalil M, Teunissen CE, Otto M, et al.. Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol. 2018, 14:577-589. 10.1038\/s41582-018-0058-z","journal-title":"Nat Rev Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.929","article-title":"Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial","volume":"301","author":"Weaver FM","year":"2009","unstructured":"Weaver FM, Follett K, Stern M, et al.. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA. 2009, 301:63-73. 10.1001\/jama.2008.929","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub D","year":"2010","unstructured":"Weintraub D, Koester J, Potenza MN, et al.. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010, 67:589-595. 10.1001\/archneurol.2010.65","journal-title":"Arch Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/nm850","article-title":"Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease","volume":"9","author":"Gill SS","year":"2003","unstructured":"Gill SS, Patel NK, Hotton GR, et al.. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med. 2003, 9:589-595. 10.1038\/nm850","journal-title":"Nat Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease: a review","volume":"311","author":"Connolly BS","year":"2014","unstructured":"Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA. 2014, 311:1670-1683. 10.1001\/jama.2014.3654","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02732-x","article-title":"Integrin Mac1 mediates paraquat and maneb-induced learning and memory impairments in mice through NADPH oxidase-NLRP3 inflammasome axis-dependent microglial activation","volume":"20","author":"Hou L","year":"2023","unstructured":"Hou L, Liu J, Sun F, et al.. Integrin Mac1 mediates paraquat and maneb-induced learning and memory impairments in mice through NADPH oxidase-NLRP3 inflammasome axis-dependent microglial activation. J Neuroinflammation. 2023, 20:42. 10.1186\/s12974-023-02732-x","journal-title":"J Neuroinflammation"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M609532200","article-title":"Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein","volume":"282","author":"Sarkar S","year":"2007","unstructured":"Sarkar S, Davies JE, Huang Z, Tunnacliffe A, Rubinsztein DC. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J Biol Chem. 2007, 282:5641-5652. 10.1074\/jbc.M609532200","journal-title":"J Biol Chem"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2020.12.008","article-title":"Impact of the coronavirus (COVID-19) pandemic on scientific research and implications for clinical academic training - A review","volume":"86","author":"Sohrabi C","year":"2021","unstructured":"Sohrabi C, Mathew G, Franchi T, et al.. Impact of the coronavirus (COVID-19) pandemic on scientific research and implications for clinical academic training - A review. Int J Surg. 2021, 86:57-63. 10.1016\/j.ijsu.2020.12.008","journal-title":"Int J Surg"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17196","article-title":"Global publication productivity in dermatology: a bibliometric description of the past and estimation of the future","volume":"35","author":"Gantenbein L","year":"2021","unstructured":"Gantenbein L, Arora P, Navarini A, Brandt O, Mueller SM. Global publication productivity in dermatology: a bibliometric description of the past and estimation of the future. J Eur Acad Dermatol Venereol. 2021, 35:1424-1433. 10.1111\/jdv.17196","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012868","article-title":"Dopaminergic therapy for motor symptoms in early Parkinson disease practice guideline summary: a report of the AAN guideline subcommittee","volume":"97","author":"Pringsheim T","year":"2021","unstructured":"Pringsheim T, Day GS, Smith DB, et al.. Dopaminergic therapy for motor symptoms in early Parkinson disease practice guideline summary: a report of the AAN guideline subcommittee. Neurology. 2021, 97:942-957. 10.1212\/WNL.0000000000012868","journal-title":"Neurology"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21596","article-title":"Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial","volume":"65","author":"Okun MS","year":"2009","unstructured":"Okun MS, Fernandez HH, Wu SS, et al.. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol. 2009, 65:586-595. 10.1002\/ana.21596","journal-title":"Ann Neurol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22735","article-title":"Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease","volume":"25","author":"Moro E","year":"2010","unstructured":"Moro E, Lozano AM, Pollak P, et al.. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord. 2010, 25:578-586. 10.1002\/mds.22735","journal-title":"Mov Disord"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1089\/ten.TEB.2021.0080","article-title":"Global research trends in dental stem cells: a bibliometric and visualized study","volume":"28","author":"Zhao H","year":"2022","unstructured":"Zhao H, Liu JB, Bao ZF, Xu YX, Wang ZQ. Global research trends in dental stem cells: a bibliometric and visualized study. Tissue Eng Part B Rev. 2022, 28:733-744. 10.1089\/ten.TEB.2021.0080","journal-title":"Tissue Eng Part B Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/290959-parkinsons-disease-treatment-a-bibliometric-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T20:57:24Z","timestamp":1726606644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/290959-parkinsons-disease-treatment-a-bibliometric-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.69613","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,17]]}}}